Review Three Synthesis Methods of CDX

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 18

www.ietdl.

org
Published in IET Nanobiotechnology
Received on 21st August 2012
Revised on 26th November 2012
Accepted on 29th November 2012
doi: 10.1049/iet-nbt.2012.0028

ISSN 1751-8741

Review: three synthesis methods of CdX (X = Se,


S or Te) quantum dots
Samad Mussa Farkhani, Alireza Valizadeh
Department of Medical Nanotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences,
Tabriz 51664, Iran
E-mail: a.valizadeh_medicalnano@yahoo.com

Abstract: Quantum dots (QDs) are one of the rst nanotechnologies to be integrated with the biological sciences that used for
imaging or tracking macromolecules/cells in cell/tissue. Because of QDs are important in biomedical and biological applications,
identify a variety of synthesis methods to produce QDs with different characteristics also is particularly important. Hence, in this
review the authors discussed three methods for synthesis of heavy metal chalcogenide-based QDs for use in biomedical eld: (i)
Organometallic method for synthesis of QDs consists of three components: precursors, organic surfactants and solvents. The
authors also discussed water-solubilisation strategies of synthesised QDs including encapsulation and ligand exchange. (ii)
Aqueous synthesis technique using short-chain thiols as stabilising agents is a useful alternative to organometallic synthesis of
CdSe, CdS and CdTe QDs. (iii) The third method discussed in this article for QDs synthesis involves the utilise of
microorganisms to prepare QDs with controlled size, shape, chemical composition and functionality. The authors also
discussed recently new methods for the synthesis of the appropriate QDs for use in biology. In addition, attachment of
biomolecules such as antibodies, oligonucleotides on the surface of QDs for specic targeting and different opinions about
toxicity of QD have been studied.

Nomenclature
QDs
TOPO
TOP
HPA
TDPA
ODE
TBP
OA
(TMS)2 S
ZnEt2
DTA
(BDMS)2 Te
HAD
TEM
HRTEM
Cd (Ac)2
DDA
BSA
TGA
GSH
MSA
APTES
AOT
CA

quantum dots
trioctylphosphine oxide
trioctylphosphine
hexylphosphonic acid
tetradecylphosphonic acid
octadecene
tributylphosphine
oleylamine
hexamethyldisilathiane
diethylzinc
dowtherm A
bis(tert-butyldimethylsilyl) telluride
hexadecylamine
transmission electron microscopy
high-resolution transmission electron
microscopy
cadmium acetate
dodecylamine
bovine serum albumin
thioglycolic acid
glutathione
mercaptosuccinic acid
(3-aminopropyl)triethoxysilane
dioctyl sulphosuccinate sodium salt
(aerosol-OT)
cysteamine

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

TAA
TP
PEG
MAA
PLQY

thioacetamide
tiopronin
polyethylene glycol
mercaptoacetic acid
photoluminescence quantum yield

Introduction

Interest in colloidal inorganic nanoparticles such as


semiconductor
nanocrystals,
metal
and
magnetic
nanoparticles has stably grown in the past two decades
because of their unique optoelectronics, magnetic and
electrical properties that are different from their bulk
structure counterpart [113]. Among the various colloidal
semiconductor
nanocrystals,
representatively
metal
chalcogenide nanocrystals, have been interested because of
their quantum connement effects and size-dependent
photoemission characteristics [14]. For biological imaging,
Cd-based chalcogenide (This term generally refers to
sulphur (S), selenium (Se), tellurium (Te) elements of the
periodic table) nanocrystals are regarded to be promising
materials [11]. Quantum dots (QDs) are semiconductor
nanoparticles including of elements from the periodic
groups IIVI or IIIV and their size are ranging between 2
and 10 nm in diameter. This ranging of diameter is close to
or smaller than the dimensions of the exciton Bohr radius.
Moreover, the mobility of charge carriers (electrons and
holes) is restricted within the nanoscale dimensions, and
59

& The Institution of Engineering and Technology 2014

www.ietdl.org
this quantum connement effect QDs with unique optical and
electronic features [15]. Owing to this size-dependent
property, the absorption and emission properties [16] of the
semiconductor QDs can be easily tuned by controlling the
particle size, shape or surface structure [17]. Fig. 1 shows a
schematic drawing representing the wavelength of light
emitted by QDs is tunable by changing the particle size.
Compared with traditional organic uorophores, QDs
process several advantages in uorescence properties for
biological applications, that including: a high brightness
because of the extinction coefcient and quantum yield,
broad absorption characteristics and a narrow band width in

emission spectra, independence of emission on the


excitation wavelength, continuous and tunable emission
maxima because of quantum size effects, and a longer
uorescence lifetime ranging from 10 to 40 ns, and stability
under relatively harsh environments [10, 18]. QDs with
careful functionalisation have been widely used for imaging
and sensing [6, 10, 1927] and tracking particles or cells
[2830] in biology and medicine. Because of these features
mentioned and the importance of medical and biological
applications of QDs, in this review, we have discussed the
three synthesis methods and also new method of CdX (X =
Se, S or Te) QDs, which is the most common commercially

Fig. 1 Schematic drawing demonstrated


a Exciton has shown when a photon is absorbed by a semiconductor
b Wavelength of light emitted by QDs is tunable by changing the particle size and their emission wavelength is narrow and symmetrical
c Series of QDs with different core sizes and emission wavelength can be excited simultaneously by a single excitation light source
60

& The Institution of Engineering and Technology 2014

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
available and used as secondary antibody conjugates for
labelling [31]. In addition, we briey discussed the
applications, toxicity, photostability of QDs and surface
engineering of QDs for use in biology.

QD materials

QDs are constructed from semiconducting materials. The


particles are generally made from hundreds to thousands of
atoms of group II and VI elements (e.g. CdSe and CdTe) or
group III and V elements (e.g. InP and InAs) [15]. QDs
composed of Group IIVI have recently drawn signicantly
interest because of their potential applications in
optoelectronics and biomedicine elds such as photovoltaic
cells and biomedical tags [3238]. Among the various QDs,
colloidal IIVI group metal chalcogenide QDs such as CdS,
CdSe and CdTe, have been studied intensively on their
quantum connement effects including size-dependent
photoemission properties, because of the latest development
in synthesis leading to high-quality QD ensembles with
narrow size distribution [39]. They are most widely utilised
QDs for biomedical eld to date [40]. Table 1 listed key
parameters of bulk semiconductors usually used for CdSe,
CdTe and CdS QDs.

Design principles of QDs for biological uses

QDs modelling for biological use includes: (i) Synthesise the


QDs: most QDs for biological environmental are based on
heavy metal chalcogenide compounds, such as CdSe and
CdTe, which can leach heavy metals in tissue. (ii) To solve
the problem of mentioned in number one, a non-heavy metal
shell, such as ZnS or CdS is used as a barrier. (iii) Adjusting
its surface so that it is biologically compatible, and then
further modifying the surface so that the QD can be directed
to a target. There are three primary ways to target a
biocompatible QD: with antibodies, peptides or small
molecules [42]. In this review, we discussed the conventional
and new methods to the synthesis of water soluble QDs.

QD structure

QDs for use in eld of biology consist of:


1. Core of QD: The central part of QDs that determines the
optical properties of the ultimate structure. The typical QDs
consist of a IIIV, IVVI, or IIIV semiconductor core (e.g.
CdTe, CdSe, PbSe, GaAs, GaN,InP and InAs) [6].
2. Shell of QD: Core of QDs has an inorganic shell. Coating
around the core is a wide band gap inorganic semiconductor
shell such as CdS or ZnS in order to minimise the surface
deciency and increase the quantum yield (QY) [43].
3. Water-soluble QD: These QDs are hydrophilic and are
soluble in water and usable in biological buffers. QDs for
use in biology need to be water-soluble. There are two
methods for making QD water-soluble: (1) Ligand
exchange (2) Encapsulation. Normally, QDs synthesised in

organic solvents have hydrophobic surface ligands such as


trioctylphosphine (TOP), trioctylphosphine oxide (TOPO),
tetradecylphosphonic acid (TDPA), oleic acid or et. In
method one these ligands of QDs surface could be replaced
by some water-soluble ligand such as thiol-based molecules
(such as mercaptocarbonic acids), peptides and other. This
is ligands exchange. QDs can also be encapsulated by a
shell of material such as silica, phospholipids, amphiphilic
polymers (poly(acrylic acid), polyethylene glycol (PEG)) to
become biocompatible and makes them more soluble in
aqueous media [18].
4. QD bioconjugate: A water-soluble QD bound to an
afnity molecule such as antibodies, peptides [44].

QD applications

The application of QDs, as a new technology for biosystems,


has been mostly studied on mammalian cells. There is an
increasing tendency to apply QDs as markers in medicine
and biology that because of their small size, brightness,
independence of emission on the excitation wavelength and
stability under relatively harsh environments [45]. They also
have excellent photostability [18] and overcome the
limitations associated with photobleaching and because of
the small structures of QDs, some physical properties such
as optical and electron transport characteristics are quite
different from those of the bulk materials [46]. Some of the
application summarised in Fig. 2 [45].

6 Stability of QDs in live cells and


photostability
The right choice of QDs diameter and monolayer structure, is
important for bioapplications of QDs. Zhu et al. [47]
discovered that by increasing the diameter of the QDs,
monolayer stability decreases. They showed that the
smallest QD studied, (2.9 nm core diameter), demonstrates
high stability in cells, against the largest QD (5.9 nm core
diameter) loses 70% of its monolayer over the 24 h. They
also showed that, when a dithiolate monolayer is replaced
by a monothiolate monolayer, the monolayer stability
decreasing by 40%. They found that QD monolayer
stability is correlated with both QD diameter and monolayer
structure, with right choice of both particle size and ligand
structure required for intracellular stability. Since the
synthesis process of QDs effect on particle size and
monolayer structure, it is important that we fully understand
the procedures and process of QDs synthesis. Also the
photostability is one of most important properties of QDs
for cell imaging, particularly for the long-term monitoring.
Ma et al. [48] studied the photobleaching of naked CdTe
QDs and bovine serum albumin (BSA) coated CdSe/CdS/
ZnS QDs under single-photon excitation and two-photon
excitation. Based on their research the BSA-coated core/
shell QDs had improved the photostability up to 45 times
than the naked QDs because of the shielding effect of the
QD shell. Manner et al. [49] discovered that the properties

Table 1 Important parameters of bulk semiconductors usually used for CdSe, CdTe and CdS QDs [41]
Material
CdSe
CdTe
CdS

Structure, 300 K

Type

Egap, eV

Lattice parameter, [A]

Density, kg/m3

wurtzite
zinc blende
wurtzite

IIVI
IIVI
IIVI

1.74
1.43
2.49

4.3/7.01
6.482
4.136/6.714

5810
5870
4820

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

61

& The Institution of Engineering and Technology 2014

www.ietdl.org

Fig. 2 Demonstrated some of QDs applications in medicine and biology [45]

of environment have signicant impact on the stability of


QDs, and the improvement of their resistance to
photooxidation may require the control of the properties of
the surrounding solvent or matrix.

Synthesis QDs

In the early 1980s, several pioneering groups began to work on


QDs [50]. Ekimov et al. in 1982 discovered the size-dependent
characteristics of ionic nanocrystals, in a glass matrix, at the
loffe Institute in St. Petersburg, Russia [51, 52]. L. Brus in
1983, reported size-dependent behaviour in colloidal CdS
nanocrystals through the measurement of size-dependent
redox potentials [53]. QDs Synthesis was rstly
accomplished by precipitation from a solution containing the
metal ion (Ag, Hg, Pb, Zn, Cd, In) by a hydroxide of S, Se
or Te followed [54]. The preparation process includes control
of the shape, size, homogeneity and the surface structure of
the QDs and this is a very important part in producing those
mentioned unique properties [55]. In this review we
discussed three popular methods and also new methods for
synthesis of QDs used for biology:
1. Organometallic synthesis: this method is the most popular
method for QDs synthesis.
2. Aqueous route for synthesis QDs: low-temperature reaction
3. Biosynthesis of QDs
4. New methods for synthesis of water-soluble QDs
7.1

Organometallic precursor synthesis of QDs

With entrance of nucleation and growth techniques to


synthesize QDs in high-temperature organic solvents,
62

& The Institution of Engineering and Technology 2014

synthesis of QDs made easier and more controllable. An


organometallic system for synthesis QDs consists of three
components: precursors, organic surfactants and solvents.
Sometimes, surfactants also serve as solvents [56]. Metal
chalcogenide-based QDs with different sizes to be
manufactured by alteration of the amount of precursors and
crystal growth time; this is important for their uorescent
properties in that their emission wavelength is dependent
upon crystal size, and hence tuneable during manufacture
[57]. In this process to create QDs, ionic sources of the
component materials such as Cd2+ are needed. This method
consists of pyrolysis of organometallic precursors into a hot
coordinating solvent to manufacture monodisperse (<5%
size dispersion) QDs composed of cadmium chalcogenides
[1]. Organometallic synthesis of QDs, invented in the early
1990s by Steigerwald and Brus [58], developed to a
practical level and for rst time controllable nucleation and
growth of narrow size distribution QDs was demonstrated
by Murray et al. in 1993 [59]. Precursors describe the
combination of the particles that are formed. When
precursors dissolved in the solvent, they decompose into
reactive species, known as monomers [60]. Steigerward
indicated that an important step to synthesis of QDs is
identifying suitable precursor molecules such as
organometallic compounds: a suitable precursor for the
synthesis QDs at the required growth temperature need to
quickly decompose to yield reactive atomic or molecular
species (the monomer) that can after that contribute to
nanocrystal nucleation and growth. The most famous
example is the use of dimethyl cadmium (Cd(CH3)2) and
trialkyl phosphine selenide to yield CdSe [61, 62]. The best
been used precursors are simple molecules with leaving
groups that readily depart to leave behind the desired
reactive specie [56]. Murray et al. use Cd(CH3)2 as the
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
cadmium precursor for the synthesis highly crystalline CdSe
QDs. Injection of Cd(CH3)2 into a hot solution can yield
supersaturation, nucleation, and subsequent growth but Cd
(CH3)2 is very toxic, unstable at room temperature and air
sensitive [63]. To solve this problems Peng and co-workers
in 2001 reported the use of CdO complexed to
hexylphosphonic acid (HPA) or TDPA, as an alternative to
Cd (CH3)2, in TOPO syntheses of QDs [64].
In synthesis of QDs, tow common events should occur: (1)
The nucleation: precursors at a high-temperature decompose
or react to form a supersaturation of monomers followed by
a burst of nucleation of nanocrystals (2) these nuclei growth
from molecular precursors (Fig. 3a). This method requires
accurate temperature control to separate the nucleation and
growth of the QDs, which solely depend on the temperature
of the mixture, injection process utilized as well as the
concentration gradient under control [65].
In this method, an injection temperature and a growth
temperature are selected. This high reaction temperature
(>150350C) has two major advantages: facilitates the
removal of crystalline defects and allows improvement in
the photoluminescence [66]. When the reaction medium is
warm enough, the precursors chemically convert into active
atomic or molecular species (monomers); these then form
nanocrystals and with utilise the surfactant molecules
subsequent growth is strongly affected [15]. In synthesis of

Fig. 3 Schematic diagram showing


a Cartoon depicting the stages of nucleation and growth for the preparation of
QDs based on La Mer model [1]
b Schematic drawing representing a synthetic apparatus employed in the
synthesis of QDs
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

chalcogenide QDs, cadmium precursors are organometallics


[67] such as Cd(CH3)2 while Se, S, Te precursors are often
from elemental source. Organic solvents, such as TOPO
[59], HDA [68], octadecene (ODE) [69] of which are high
boiling point solvents containing long alkyl chains and have
the ability to create high reaction temperature (200400).
Table 2. Lists common precursors, solvents and stabilisers
used in the synthesis of chalcogenide-based QDs. ODE has
several advantages compared with other solvents such as:
good dissolving power, environmentally friendlier, stability
in air, less toxicity, low cost, low melting point (below 20
C) and this makes it easier to be handled at room
temperature. Furthermore, it has a high boiling point
(approximately 360C) coupled with its inert nature to the
Se precursor, and which makes it an ideal solvent for the
growth of high-quality QDs [70]. These molecules serve
three major purposes:
1. The reaction medium for solubilise and diffuse the
nanocrystals and the reactants involved in the growth.
2. Coordinate with unsaturated metal atoms on the QDs
surface to prevent the formation of bulk QDs.
3. They can control the speed of the reaction.
To do so, the solvent molecules require attaching and
unbinding dynamically on the surface of the growing
nanocrystals. With separating one molecule from the
surface of the nanocrystal, monomers can be incorporated
into the nanocrystal, and thus it can grow [71]. Used
surfactant for synthesis QDs needs to be able to exchange
on and off the growing crystals, such that regions of the
nanocrystal surface are transiently available for growth, yet
total crystals are on average monolayer protected to block
aggregation. These molecules display tow domains: one
non-polar, usually a long alkyl chain, and a polar head
group. Non-polar tail affects the diffusion properties, while
the polar head group generally affects the binding efciency
[71]. The surface of energy with which surfactant molecules
present in the growth medium stick to the surfaces of
growing nanocrystals is one of the most important
parameters inuencing crystal growth [56]. Examples of
surfactants consist of fatty acids, amines, some
nitrogen-containing aromatics and molecules with very long
chains of carbon atoms (alkyl chains) such as alkyl
phosphine oxides, alkyl phosphonic acids and alkyl
phosphines that dynamically solvate nanocrystals [56].
Function of capping agents: with growth of nuclei, van der
Waals forces can cause quick coalescence of nuclei and
uncontrolled particle growth. Ligands such as stearic acid,
myristic acid, oleic acid and TOP are chemically bonded to
both the precursors and to the particles that form. Such
bonds resist van der Waals interactions. These molecules
may be added during the synthesis of QDs to adsorb and
restrict particle particle agglomeration, although such
molecules may, in principle, prevent monomer
sedimentation too. Additionally, it is possible that
complexation of capping agents to the active species and
precursors may hinder nucleation, which will subsequently
lead to larger, rather than smaller, particle sizes [69].
Optimisation of QDs synthesis conditions were carried out
by systematically changing the reaction condition including,
the effect of type of solvent [80, 81], form of surfactant
[78], precursor form [67], reaction temperature [82] and
working to increase the QY and monodispersity. The
reaction is normally performed in three-neck asks connect
63

& The Institution of Engineering and Technology 2014

www.ietdl.org
Table 2 Precursors, solvents and stabilisers used in the synthesis of chalcogenide-based QD
QDs

Size of
particles

Solvent

CdSe/ZnS

2.35.5 nm

TOPO

CdSeCdS
CdTe
CdSe
CdTe
CdSeCdS
CdTe
CdSe/CdS
CdS
CdSe
CdSeCdTe
CdS
CdSe/CdS/ZnS

1.211.5 nm

Precursors and stabilisers

Refrences

TOPO

CdMe2, diethylzinc (ZnEt2), TOP-Se, hexamethyldisilathiane


(TMS)2 S
(TMS)2S or (TMS)2Se or (BDMS)2Te CdMe2/TOP

[59, 73]

1.525 nm
2.57 nm
28 nm

TOPO
DDA
TOPO

Cd(Ac)2 or CdO or CdCO3, TOP-Se, stearic acid or lauric acid


CdMe2,TOP-Te
CdO,TOP-Se or TOP-Te or TOP-S ,TDPA

[73]
[74]
[75]

2.94 nm
3.8 nm
4.05 0.16 nm
ND
5.1 nm
7 nm

TOPO-ODE-DTA-T66
ODE
HDA, TOPO
TOPO
OA
HDATOPO

TOP-Se, CdO, Cd/oleic acid


myristic acid, Cd(Ac)2, S
TOP-Se, CdMe2/TOP
TOP-Se, CdMe2/TOP, H2Te, Cd(ClO4)2
CdCl2, sulphur/OA, TOPO
Cd(Ac)2, TOPSe, H2S, Zn(C2H5)2 (TMS)2 S, TOP

[76]
[77]
[78]
[79]
[14]
[68]

[72]

ND - not determined

to a Schlenk line (vacuum gas manifold) with one of the


necks. The remaining tow necks are sealed with rubber
septa and serve for the injection of reactants and the
measurement of the temperature reaction medium (Fig. 3b).
The reaction typically is performed under an inert
atmosphere, because molecules of reactant may be
pyrophoric and furthermore some types of nanocrystals may
be sensitive to air. To begin the QDs synthesis, this ask
loaded with the organic solvent and surfactant molecules,
then organic molecules are molten from powder state to a
liquid and the ask is evacuated and kept under vacuum at
150300C for 1020 min to remove volatile impurities
[71]. Elemental chalcogens (S, Se and Te) are introduced
into the reaction medium as a complex with capping agent
such as TOP or tributylphosphine (TBP). In this procedure,
the complex is produced by dissolving the S, Se or Te in
liquid TOP or TBP [71].
Organometallic precursor synthesis produces CdSe, CdS or
CdTe QDs, but has a comparatively low-QY (brightness),
usually <10%, requiring a shell of a high band-gap
semiconductor, such as CdS or ZnS to be epitaxially grown
around the core, which increases the QY up to 80%. This
layer moreover protects the core from oxidation and
prevents leaching of the Cd/Se [83].
7.1.1 Water-solubilisation strategies: QDs synthesised
with organometallic method in non-polar solutions using

aliphatic coordinating ligands (such TOPO) are only soluble


in non-polar organic solvents [84]. These QDs must
therefore be modied to become soluble in water and
compatible with the biological environment. Two general
strategies have been developed for this purpose: ligand
exchange and Encapsulation within block copolymer shells
and phospholipid micelles (Fig. 4). Ligand exchange
consists in replacing the hydrophobic ligands with new
ligands presenting anchoring groups to bind to the QDs
surface and hydrophilic solubilising groups [85]. Examples
of water-soluble bifunctional molecules used for ligand
exchange method are Aminated polymers, DHLAPEG
derivatives, Thiol--D-lactose, peptides and so on. [18, 86].
QDs generated with this method are useful for biological
environment, but ligand exchange is usually in association
with decreased QY and a tendency to aggregate and
precipitate in biological buffers. Lately, it has been shown
that these problems can be alleviated by keeping the
hydrophobic ligands on the surface, and covering the QDs
with amphiphilic molecules [84]. Examples of amphiphilic
molecules used for QDs encapsulation are phospholipid
micelles
or
amphiphilic
copolymers
such
as
-cyclodextrine, polymer microsphere and etc. [85, 86].
Coating with polymers may increase the size of the QDs by
as much as 510 nm depending on the coating. In addition,
the silica-coating method has also been used to
water-solubilisation of QDs. Hydrophilic ligands used in

Fig. 4 Schematic representation of the surface functionalisation strategy based on ligand exchange and encapsulation of the QDs within
phospholipid micelles
64

& The Institution of Engineering and Technology 2014

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
Table 3 Comparison of some characteristics such as size, electronic transition energies, crystal structure and photoluminescence
behaviour of CdSe QDs capped with different stabilisers [93]
Stabiliser
crystal structure
photoluminescence
1s1s electronic transition, nm
diameter, nm

2-mercaptoethanol

1-thioglycerol

TGA

cubic CdSe (zinc blende)


trapped
360450
1.42.2

cubic CdSe (zinc blende)


trapped
360450
1.42.2

cubic CdSe (zinc blende)


trapped
450530
2.13.2

these two strategies may be composed of charged moieties


(carboxylic acids, amines,), however these present limited
stability and high non-specic adsorption of biomolecules
on their surface. PEG chains are more common for in vivo
applications because it decreases signicantly this
non-specic adsorption, and increases the stability and
circulating time of QDs [85, 87]. It must be considered that
many biological and physical properties of the QDs may be
affected by the surface coating, and the overall physical
dimensions of the QDs are dependent on the coating
thickness [84].
7.2

Aqueous route for synthesis QDs

Typically, CdSe nanocrystal synthesis includes the use of Cd


(CH3)2 with TOPO. The raw materials such as
organometallics, in QDs synthesis are particularly
pyrophoric, unstable, costly, toxic, and the reactions often
lack control and reproducibility [8890]. Moreover, their
surface (capped by TOPO), is hydrophobic and QDs cannot
be directly applied in bio-labelling. After the substitution of
the surface-capping molecules on QDs by hydrophilic
molecules (such as thiol groups or amines), their
photoluminescence signicantly decreased [32, 91]. Direct
aqueous synthesis of QDs such as CdS [92], CdSe [93],
CdTe [94, 95], by applying different thiol groups as
stabilising agents provides a effective alternative to widely
used synthetic routes in highly boiling organic solvents.
The use of thiols makes possible to control the kinetics of
the QDs synthesis, passivate surface dangling bonds, and
provides stability, solubility and surface functionality of the
nanoparticles [96]. In this method the ligands used during
formation of QDs become the eventual biocompatible
surface ligands and do not need an exchange process [97].
For synthesis of QDs in water directly, Vossmeyer et al.
[92] used Cd(C1O4)6H2O, H2S and 1-thioglycerol as the
precursors for the aqueous synthesis of CdS. A group of
researchers have synthesized the CdS-mercaptoacetic QD
using mercaptoacetic acid (MAA) as the stabilising agent in

the aqueous solution [98]. Using this method, CdSe


nanoparticles have been synthesised through the addition of
freshly prepared oxygen-free NaHSe solutions to
N2-saturated Cd (ClO4)2.6H2O solutions at pH 11.2 in the
presence of different thiols as stabilising agents. In this
procedure, particle size of CdSe was controlled by choosing
different types of stabilizer and through size-selective
precipitation. Table 3 summarised several characteristics of
the series of thiol-stabilised CdSe QDs with different sizes
[93].
In aqueous route, the common synthetic procedure follows
a similar route for all nanocrystals: First a metal salt (such as
Cd(ClO4)2) is dissolved in water in the presence of the thiol as
the stabilising agent. The original solution need to purge by
inert gas (mainly N gas) before the chalcogen source is
injected. The common thiols used in this procedure for
synthesis
were
2-mercaptoethanol,
1-thioglycerol,
thioglycolic acid (TGA), thiolactic acid [44, 92, 93],
1-mercapto-2-propanol and 1, 2-dimercapto-3-propanol.
Among the mentioned stabilising agents, the thioalcohols
(2-mercaptoethanol
and1-thioglycerol)
are
effective
size-regulating and stabilising agents for cadmium
chalcogenide nanoparticles [93]. Table 4 lists some of the
stabilising agents and precursor used for synthesis QDs and
size of formed QDs with this method. In the initial step for
QD synthesis, heating of the reaction solution may be
useful in order to begin particle growth. Therefore this
preparative approach based on the separation of nucleation
and growth very similar to the extremely successful TOP/
TOPO preparation of IIVI semiconductor QDs [44].
Nevertheless, second similarity between the two strategies
is the post-preparative treatment by using size-selective
precipitation to the crude cluster solutions [54].
For instance, Gaponik et al. [94] show a typical standard
aqueous synthesis of thiol-capped CdTe nanocrystals with a
naturally sulphur-capped surface (CdS shell) created by
mercapto-groups covalently attached to the surface
cadmium atoms (Fig. 5): 0.985 g (2.35 mmol) of
Cd(ClO4)2 6H2O is dissolved in 125 ml of water, and 5.7

Table 4 Lists some of the stabilising agents and precursor used for synthesis QDs and size of formed thiol-stabilised QDs
QDs

Size

Precursor

Stabilising agents

References

CdTe

1.32.4 nm
NA

Cd(ClO4)2 6H2O-NaHTe
Cd(ClO4)2 6H2O-H2Te

[94, 95, 99]


[73]

NA
5 0.5 nm
5.5 0.5 nm
1.42.2 nm
2.13.2 nm
1.33.9 nm
35 nm

CdCl2-NaHTe
Cd(ClO4)2 6H2ONaHTe
Cd(ClO4)2 6H2O-H2Te
Cd(ClO4)2 6H2O-NaHSe

2-mercaptoethanol, 1-thioglycerol
2-mercaptoethanol, 1-thioglycerol,
2-mercaptoethylamine (MA),
L-cysteine, 2-(dimethylamino)ethanethiol
mixture (1:1) of 1-thioglycerol and
2,3-dimercapto-1-propanol, TGA
3-mercaptopropionic
dithiol-functionalised ionic liquid (dTFIL)
mercaptopropionic acid
2-mercaptoethanol, 1-thioglycerol
TGA, thiolactic acid
1-thioglycerol
thioglycerol

CdSe
CdS

Cd(ClO4)2 6H2O-H2S
CdSO4Na2S2O3 5H2O

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

[77]
[100]
[96]
[93]
[92]
[43]

65

& The Institution of Engineering and Technology 2014

www.ietdl.org

Fig. 5 Schematic presentation of the synthesis of thiol-capped CdTe QDs


First stage: formation of CdTe precursors by introducing H2Te gas
Second stage: formation and growth of CdTe nanocrystals promoted by reux [94]

mmol of the thiol stabiliser are added under stirring, followed


by adjusting the pH to the appropriate values (depending on
the stabiliser nature) by dropwise addition of 1 M solution
of NaOH. The solution is placed in a three-necked ask
tted with a septum and valves and is purged by N2 for
about 30 min. Under stirring, H2Te gas is passed through
the solution together with a slow nitrogen ow. H2Te can
produce by the reaction of 0.2 g (0.46 mmol) of Al2Te3
lumps with 1520 ml of 0.5 M H2SO4 under N2
atmosphere. H2Te gas can be generated by at least two
different methods: (1) electrochemical reduction of Te
electrode in acid, Te0 + 2H+ + 2e H2Te; (2) by
chemical decomposition Al2Te3 powder or lumps, Al2Te3
+ 3H2SO4 3H2Te + Al2(SO4)3. Control of pH is very
important factor which strongly inuenced the PLQE of
thiol-capped QDs. Li et al. indicated signicantly improved
the quantum yields of CdTe QDs up to 4067% at lower
pH value (88.2) [101]. Rogach et al. demonstrate that
optimise pH (12) and molar ratio of thiol to Cd ions (1.3:1)
increases the room-temperature photoluminescence quantum
efciency of as-synthesised CdTe capped by TGA to values
of 4060%.
Vossmeyer et al. have synthesized CdS with aqueous route:
a solution of 1.97 g (4.70 mmol) of Cd (ClO4)2 6H2O and 1
ml (11.53 mmol) of 1-thioglycerol in 250 ml of water was
adjusted to pH 11.2 with 1 M NaOH. The particle size was
controlled by the quantity of H2S added as well as the
temperature and duration of further heating. Thus, sample
was prepared by the addition of 25 ml (1.12 mmol) of H2S
and stirring for 2 h at room temperature [92].
Rogach et al. in 1999 produce aqueous colloidal solutions
of CdSe nanoparticles: a solution of 1.97 g (4.70 mmol) of Cd
(ClO4)2 6H2O and 11.54 mmol of the stabiliser (RSH) in
250 ml of demineralised water was adjusted to pH 11.2
with 1 M NaOH. The solution was placed in a three-necked
ask tted with a septum and valves and was purged with
N2 gas for 30 min. Under vigorous stirring, 44 ml (2.2
mmol) of the freshly prepared oxygen-free 0.05 M NaHSe
solution was injected. Solutions were reuxed for different
times (up to 12 h), and aliquots were removed at regular
intervals (1530 min) with absorption spectra taken to
monitor the growth of the clusters [93]. The method of
size-selective precipitation [54] was used to separate the
samples of CdSe nanoparticles with different sizes and
narrow size distributions from crude solutions.
66

& The Institution of Engineering and Technology 2014

7.2.1 Effective parameters for the synthesis of QDs


with aqueous route [102]:
1. Effect of reactant concentration: The Cd:Te, Cd:S, Cd:Se
molar ratio used for QDs synthesis plays an important role in
the quality of the resultant QDs.
2. Effect of precursor pH: The pH of the precursor solution is
a key factor that inuences the QY as well as the QDs growth
rate. The pH of the precursor solution for synthesis QDs was
kept within 89 because for CdTe/CdS QDs pH higher or
lower than this range causes particle aggregation resulting
in the decrease of their uorescence property.
3. Effect of heating temperature: The structure of the QDs
surface is dependent on the reaction temperature. Faster
growth rate because of higher temperatures minimises the
formation of surface defects and thus develop the
uorescence properties of the QDs. One important benet
of aqueous synthesis is that it permits high-temperature
synthesis of QDs.
4. Effect of heating time: Heating time is directly
proportional to the size of the QDs. Longer heating time
formed larger QDs that emitted at higher wavelengths.
Aqueous method for synthesis of QDs used in biology
research has several advantages and disadvantages
compared with organometallic approach. In Table 5,
compare of aqueous synthesis against organometallic
approach and shown advantages and disadvantages of
aqueous synthesis compared with organometallic approach.
7.3

Biosynthesis of QDs

The organometallic method and water-based syntheses are


two successful routes for produce the highly uorescent
heavy metal chalcogenide-based QDs [103]. However, the
recent methods involve highly toxic chemicals, such as
TOP or TOPO, high temperatures and non-polar solvents in
the synthesis procedure and limited their applications in
clinical elds [104]. Thus, development of clean,
biocompatible, non-toxic and eco-friendly methods for QDs
synthesis has very importance [105]. More recently, the
biosynthesis of QDs has been developed and attracted
signicant attention. This method for QDs synthesis
involves the utilise of biological organisms to prepare QDs
with controlled size, shape, chemical composition and
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
Table 5 Compare of aqueous synthesis against organometallic approach
Advantages

Disadvantages

1. low cost

1. QDs synthesised by this method do not possess the degree of


crystallinity of the organometallically prepared QDs. In
organometallic synthesis can produce QDs with high quantum
yields and the size distribution can be easily controlled by alerting
temperature or reaction time [55, 94]. QDs with narrower particle
size distribution is obtained with organometallic method [94]

2. aqueous synthesis of thiol-capped QDs can be carried out


equally efficiently on a vast scale
3. synthesised QDs with this method can be precipitated, washed
and reserved in the dry state under ambient conditions as long as 2
years being stable and dissolvable in water
4. ease and high reproducibility
5. the smaller QDs are obtained with aqueous approach [94]
6. this method is environment-friendly
7. the possibility of controlling the surface charge and other surface
properties of QDs synthesis with aqueous process simply by the
selection of the stabilising agent with suitable free functional
groups is absolutely important, particularly when water-soluble
nanocrystals are needed, for example, for fluorescent tagging
applications [55, 94]
8. QDs synthesised via the organometallic method require an extra
processing step to achieve biocompatibility but in aqueous
synthesis the ligands used during formation of QDs become the
eventual biocompatible surface ligands and do not need an
exchange process [97]
9. safe reactants used in synthesis of QDs

functionality [90]. The synthesis of QDs using


microorganism is a comparatively new and unexplored area
and is cost effective, non-toxic, reproducible and can be
achieved at ambient temperatures and pressure [106]. Heavy
metals for instance Cd, inuence the microbial population
by affecting their growth, morphology, damage the cell
membranes, alter enzymes specicity, disrupt cellular
functions, damage the structure of the DNA and nally
resulting in decreased biomass and variety [107, 108].
Microbial populations exposed to toxic concentrations of
Cd and heavy metals have developed four main tolerance
mechanism [109].
1. Modication of membrane transport systems involved in
initial accumulation, thus denying or reducing entry of
cadmium [110].
2. Intracellular or extracellular suppression by specic
binding to a biopolymer, generally the cell wall [111, 112].
Tolerance to heavy metals can also be achieved by
extracellular precipitation with microbially produced
oxalate, phosphate or sulphide [113115] or extracellular
polymers [116].
3. Energy-dependent ion efux [117].

4. Detoxication by enzymatic oxidation or reduction of the


ion to a less toxic form or covalent modication [117].
With mentioned mechanisms, microorganisms such as
bacteria and fungi can produce QDs when encounter with

Fig. 6 Photographs showin


a TEM and
b HRTEM images of extracellularly biosynthesised CdTe QDs [121]

Table 6 List of some microorganisms that synthesise CdS, CdTe and CdSe QDs
QDs type
CdS

CdTe
CdSe

Size

Microorganism/morphology

Localisation

References

520 nm
25 nm
22.5 nm
ND
8.01 0.25 nm
ND
5200 nm
20200 nm
30 nm
23 nm
23.6 nm
915 nm

F. oxysporum
E. coli
Schizosaccharomyces pombe
Candida glabrata
R. palustris
Clostridium thermoaceticum
Klebsiella pneumoniae
Klebsiella aerogenes
Gluconoacetobacter xylinus
E. coli
S. cerevisiae
F. oxysporum

extracellular/hexagonal
intracellular/spherical
intracellular/hexagonal
intracellular
intracellular/cubic
cell surface
cell surface
cell wall/spherical
cellulose bre/spherical
extracellular/spherical
extracellular/cubic zinc blende
intracellular/spherical

[118]
[120, 123]
[124, 125]
[124]
[119]
[126]
[127]
[128]
[129]
[121]
[103]
[106]

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

67

& The Institution of Engineering and Technology 2014

www.ietdl.org
Table 7 New methods for synthesis of bioapplicable QDs
QDs

CdS

Synthesis methods

solvothermal technique
non-injection one-pot method without
nucleation initiators
sono-micro-emulsion method

CdSe
CdSe/
CdS

CdSe/
Cdx Zn1
xS
CdSe

3 nm
4.2
0.2 nm
2 nm

one-pot non-injection hydrothermal

3.5 nm

high-intensity ultrasonic irradiation

6 nm

Elemental
sources-solvent-capping
ligand
S dissolved in ethylene
glycol, Cd(NO3)2
cadmium stearate, S
powder,
N-oleoylmorpholine
CdCl2, S, p-xylene,
ethylenediamine, CTAB,
1-butanol
CdCl2 2.5H2O, thiourea,
MPA
CdCl2, Na2SeSO3, MAA

aqueous synthesis

3.4 nm

CdCl2, H2Se, H2S

microemulsion-based technique

4.88 nm

Cd(NO3)2, Se, Na2SO3,


(NH4)2S, AOT, n-heptane

organic route

5.47.2
nm

Cd(AC)2 2H2O, S, Se, Zn


(AC)2, TOP, OA, TOA

high-intensity ultrasonic irradiation

13 nm

CdCl2, Na2SeSO3, MAA

green synthetic route


green synthetic route protein-directed
aqueous synthetic
CdTe

Particle
size

layer-by-layer method

5 nm

CdCl2, Se, BSA


2

4 nm

CdCl2, Se aqueous
solution, Lyz

2.3 nm

CdCl2 2.5H2O, SeO2,


NaBH4, TGA
CdCl2, NaHTe, TGA,
APTES

5 nm

photochemical synthesis

5.9 nm

CdCl2, NaHTe, TGA

aqueous synthesis

26 nm

CdCl2, NaHTe, L-cysteine

hydrothermal synthesis

3 nm

CdCl2, NaHTe, GSH, TGA

CA-CdTe

hydroxylamine-hydrochloride-promoted

4 nm

CdCl2, Na2TeO3, NaBH4,


NH2OH HCl, CA

CdTe/
CdSe

hydrothermal synthesis

4.8 nm

CdCl2 2.5H2O, Na2TeO3,


Na2SeO3, MPA

CdTe/
ZnS

aqueous synthesis

3.7 nm

CdCl2 2.5H2O, NaHTe,


ZnCl2, GSH

CdTe/
CdS

hydrothermal treatment method

3.5 nm

CdCl2 2.5H2O, Na2TeO3,


MSA, NaBH4, Na3C6H5O7

aqueous-phase synthesis

3 nm

heavy metals. Many microorganisms, such as Fusarium


oxysporum [118], Rhodopseudomonas palustris [119] have
been used to synthesise CdS QDs. Mi et al. [120] were
prepared CdS QDs in genetically engineered Escherichia
coli through the introduction of foreign genes encoding a
CdS-binding peptide. The CdS QDs were successfully
separated from the bacteria through two methods: lysis and
68

& The Institution of Engineering and Technology 2014

CdCl2 2.5H2O, NaHTe,


TP, TGA, GSH, TAA

Advantages

References

soluble CdS, highly stable,


stabilise without capping
agent
cost-effective, large-scale
production, green

[135]

simplicity, uniform shape,


synthesis at low
temperature
water-dispersible, high
crystallinity, high
photochemical stability
water soluble, increased
PLQY
low-toxic chemicals,
large-scale, water-soluble,
controllable introduction of
Se and S sources
simple, green, large-scale
synthesis, water-soluble,
bio-taggable
less toxic, insensitive to air,
easier to purify

[137]

water-soluble, easy control


of reaction conditions
water-soluble,
biologically-compatible
water-soluble, excellent
uorescent QDs, specically
biological function
less toxic, good stability

[142]

excellent molecules
recognition ability,
inexpensive, water-soluble,
environment-friendly
environment-friendly, high
photo stability
water-soluble, good
uorescent properties, short
synthesis period, the
broaden range of starting
pH value, less toxicity
good biological
compatibility, optical
stability
water-soluble, very simple
synthesis method, excellent
stability
water-soluble, excellent
photo stability, good
monodispersity
less toxicity, better
biocompatibility,
environmental friendly
low cytotoxicity, higher
chemical stability in a pH
range of 69, water-soluble
environmentally friendly,
highly biocompatible,
simple

[136]

[138]
[130]
[139]

[140]
[141]

[143]
[144]
[145]
[146]

[147]
[148]

[149]
[150]
[151]
[152]
[153]
[154]

freezingthawing of cells. In one study, Bao et al.


demonstrate a easy and efcient biosynthesis of highly
uorescent CdTe QDs with uniform size (2.03.6 nm) by
incubating a type of widely used and easily cultured
microorganism yeast cells (Saccharomyces cerevisiae)
with inexpensive inorganic Cd and Te salt precursors,
which has a high yield of nearly 90%. The extracellularly
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
bio-grown CdTe QDs can be easily harvested and show
tunable size-dependent emission from 490 to 560 nm with a
relatively high photoluminescence quantum yield (PLQY)
of 33%. In addition, the CdTe QDs are naturally capped
with proteins in the biosystem, and show excellent water
solubility, great stability and biocompatibility for use in
biology eld [103]. Fig. 6a shown TEM image of the CdTe
QDs synthesised in E. coli (B) The high-resolution TEM
micrograph shown the size of the QDs is 23 nm.
Kumar et al. [106] showed that plant pathogenic fungus
F. oxysporum when challenged with aqueous CdCl2, SeCl4
at room temperature for 96 h under shaking conditions on a
rotary shaker (200 rpm) resulted in the formation of highly
stable CdSe nanoparticles possessing the following
characteristics: 11 nm, polydisperse, with broad
photoluminescence spectrum and 67 ns uorescence
half-life.
Microbial synthesis of QDs can be done either intracellular
or extracellular. The extracellular synthesis of semiconductor
nanoparticles makes it possible to harness and immobilise/
deposit such nanoparticles onto desired solid surfaces for
different practical purposes and has wider applications in
optoelectronics, bioimaging and in sensor technology than
intracellular accumulation. In the intracellular production,
the accumulated particles have less polydispersity. In order
to release the intracellularly synthesised QDs, extra
processing steps for example ultrasound treatment or
reaction with suitable detergents are required [106, 122].
Albeit biosynthesis of QDs are regarded as safe,
cost-effective, sustainable and eco-friendly processes, they
also have some disadvantages in culturing of microbes,
which is time-consuming and difcult in providing better
control over size distribution, shape and crystallinity. QDs
prepared by this method are also not monodispersible and
the rate of production is slow. These are the problems in
synthesis of QDs with microorganisms, but the information
obtained from strain selection, optimising the conditions
such as pH, incubation temperature and time, concentration
of metal ions, and the amount of biological material has

come up to give hope in achievement of these approaches


in large scale and for biomedical applications [122].
The microbial synthesis of QDs meets some challenges:
1. Improved control over size and shape
2. Scaling up of the synthesis to obtain large amount of QDs
3. Understanding the synthesis mechanism at the molecular
level, which nally may help in providing better control
over size, shapes and crystallinity in the future [120].
Table 6 shows some microorganisms that synthesise CdS,
CdTe and CdSe QDs.

8 Recent efforts to synthesise QDs for


biomedical applications
We have noted that QDs prepared by organometallic methods
are hydrophobic and need additional chemical modication to
make them water-soluble. This process is usually
time-consuming and causes a decrease in PL efciency.
QDs synthesised with aqueous and biosynthesis methods
have problems such as low crystallinity, wider particle size
distribution, low QY and time-consuming and therefore,
these methods should be improved. So, new methods for
the synthesis of appropriate QDs for biomedical
applications are needed. Bao et al. synthesised CdSe and
CdSe/CdS
QDs
in
aqueous
solution
with
ultrasound-assistance by using MAA as the capping ligand.
The PLQY of CdSe/CdS QDs were increased 3 times more
than that of the original CdSe by around 3 times [130]. A
group of researchers reported a protocol for biomimetic,
mild chemical synthesis of CdTeglutathione (GSH) QDs
in microorganisms with improved biocompatibility. They
have used CdCl2, k2TeO3 and GSH, and highly uorescent
QDs were synthesised when microorganisms grew. Toxicity
of CdTe QDs was lower than that observed with QDs
produced by other methods [131]. Recently, a new method
developed for the synthesis of CdS QDs through
micro-emulsion (O/W) induced by ultrasound. QDs with a

Fig. 7 Schematic presentation of steps involved in the bioconjugation of QDs [155]


IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

69

& The Institution of Engineering and Technology 2014

www.ietdl.org
Table 8 More details for toxicity of QDs are shown in table [45, 160, 161]
QD

Model

Administration

QD
concentration

Exposure
duration

Toxicity

Reference

CdSe/ZnSSSA

EL-4 cells

1 106 cells/well

0.10.4 mg/ml

024 h

[162]

CdSe/ZnSSSA

EL-4 cells

200 l cell
suspension
injected (iv) into
mice
5 104 cells/ml

0.1 mg/ml QDs


per 5 107 cells

2 h to 7 days

cytotoxic: 0.1 mg/ml


altered cell growth;
most cells
non-viable at 0.4
mg/ml
no toxicity in mice
in vivo

12 M

12 h

vero, HeLa and


primary human
hepatocytes

100 l QDs/3
104 cells

00.4 mg/ml

24 h

rat
pheochromocytoma
cells, murine
microglial cells
primary rat
hepatocytes

1 105 cells/cm2

0.01100 g/ml

224 h

62.51000 g/ml

18 h

xenopus blastomeres

5 109 QDs/cell
(0.23 pmol/cell)

Days

mice

200-l tail vein


injection

1.53 nl of 2.3
M QDs
injected, 2.1
9
10 to 4.2 109
injected QDs/
cell
Injections;
180 nM QD,
20 pmol QD/g
animal weight
400600 nM

15 min cell
incubations,
1133 days in
vivo
4560 min

no signs of
localised necrosis at
the sites of
deposition
no effects on cell
growth

0.51.0 M

15 min

[168]

60 M QD/g
animal weight,
1 M and 20 nM
nal QD
concentration
100 l of
B16F10 cells
used for tail
vein injection,
2 105 to 4
105 cells
injected
0.24 mg/ml

not given

no effect on cell
growth,
development
mice showed no
noticeable ill effects
after imaging

46 h cell
incubation,
mice
sacriced at
16 h

no toxicity observed
in cells or mice

[170]

2h

0.4 mg/ml MUA/


SSAQD complexes
did not affect
viability of vero
cells
10 nM QD had
minimal impact on
cell survival
nearly completely
inhibited cell growth
even from the very
beginning
at 1 nM did not
initiate any
detrimental effects;
at 100 nM resulted
in the death of all
cells

[171]

CdSe/ZnS conjugates:
NH2, OH, OH/COOH,
H2/OH, MUA, COOH
CdSe/ZnSMUA

CdTe

CdSeMAA, TOPO
QDs

QD micelles: CdSe/
ZnS QDs in (PEGPE)
and
phosphatydilcholine
CdSe/ZnS amp-QDs
and mPEG QDs
CdSe/ZnSDHLA
avidin-conjugated
CdSe/ZnS QDs
CdSe/ZnS
amphiphilic micelle

WTK1 cells

dictyostelium
discoideum and HeLa
cells
HeLa cells
mice

tail vein injection

CdSe/ZnSDHLA QDs

mice, B16F10 cells

5 104 B16F10
cells with 10 l
QDs (10 pmol),
tail vein (iv)
injection

CdSe/ZnSMUA QDs;
QDSSA complexes

vero cells

0.4 mg/ml

CdSe/ZnS

HeLa cells

1 106 cells

HEK293 cells

PC12 cells

CdTe aqQDs

CdTe-gelatinised/
non-gelatinised

10 days (cell
culture)

1 105 cells

10 pmol QDs/
1 105 cells
(10 nM)
300 or 600 nM

1 105 cells/cm2

1 to 100 nM

72 h

3 days

[162]

2 M QDCOOH
induced DNA
damage at 2 h
cytotoxic: 0.2 mg/
ml, vero; 0.1 mg/ml,
HeLa; 0.1 mg/ml,
hepatocytes
10 g/ml cytotoxic

[163]

cytotoxic: 62.5 g/
ml cytotoxic under
oxidative/photolytic
conditions no
toxicity on addition
of ZnS cap
5 109 QDs/cell: cell
abnormalities,
altered viability and
motility No toxicity
at 2 109 QDs/cell

[166]

[164]

[165]

[167]

[24]

[168]

[169]

[172]
[173]

[174]

Continued

70

& The Institution of Engineering and Technology 2014

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
Table 8 Continued
QD

Model

Administration

QD
concentration

Exposure
duration

Toxicity

Reference

K562 and HEK293T


human cell lines

1 105 cells

0.23.0 M

048 h

[175]

CdSe/ZnSPEG
(EviTag T1 490 QD)

caco-2 (human colon


carcinoma) cell line

106 cells/ml, 0.2


ml/well

0.84105 M

024 h

CdSe

primary rat
hippocampal neuron
cells in culture

104105 cells/ml

1, 10 and 20 nM

24 h

cells treated with


CdTe and CdTe/CdS
QDs were mostly
non-viable by 48 h
(for all
concentrations
tested)
commercially
available QD
demonstrated low
cytotoxicity but
induced cell
detachment
1 nM QD for 24 h
showed no
decrease in cell
viability; in contrast,
cells treated with 10
and 20 nM QD for
24 h showed
decreases in cell
viability of the order
of 20 and 30%

CdTe, CdTe/CdS,
CdTe/CdS/ZnS

hexagonal phase were prepared at a relatively low temperature


(70C), short time and fast transition phase. The main point of
this work is to achieve the CdS QDs in the presence of
ultrasound without additives and calcinations [132]. Zhao
et al. reported the preparation of a series of water-soluble
CdSe and CdSe/CdS QDs using amino acid-modied -CD
as surface coating agent by a simple sonochemical method.
These QDs are very soluble and stable in biological buffer,
and have appropriate size, high colloidal stability, good
biocompatibility, low toxicity and strong optical emission
properties [133]. Water-soluble CdSe QDs have been
prepared by a new tow-step method. First, H2Se was
produced by the reaction of the Na2SeSO3 solution with
diluted H2SO4, and then was ventilated into Cd2+ capped
with 3-MPA solution to form QDs nucleus; second, CdSe
solution was poured into a Teon-lined stainless steel
autoclave to obtain the desired CdSe QDs by controlling
the particles growth time and temperature. The results show
the water-soluble CdSe possess higher purity and PLQY,
improved photostability, and less synthetic time as
compared with aqueous CdSe QDs obtained by other
methods [134]. Table 7 summarised recent new methods for
synthesis of bioapplicable QDs.

9 Attachment of molecules on the surface of


QDs for targeting (bioconjugation)
Biocompatible QDs have to be cross-linked to biomolecules
such antibodies, oligonucleotides, nucleic acids or small
molecule ligands to render them specic to biological
targets and therefore be used for diagnosis and targeting
drug delivery. For bioconjugation, these molecules can be
attached either covalently or non-covalently on the surface
of QDs. QDs attached to small molecule ligands, inhibitors,
peptides or aptamers can bind with high specicity to many
different cellular receptors and targets. Functional ligands of
QDs surface such as carboxylic acids, primary amine and
thiol can be conjugated with antibodies and peptides by
exploiting cross-linking chemistry of carbodiimide,
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

[176]

[177]

maleimide
and
succinimide.
Also,
avidinbiotin
cross-linking is one of the most popular methods for
conjugating biomolecules on the surface of QDs [84, 87,
155]. These methods are shown in Fig. 7.

10

QD toxicity

Toxicity of QDs for biological applications is a critical factor.


There are different opinions about toxicity of QD. Yan et al.
shown that QDs could not only impair mitochondria but also
exert endothelial toxicity through activation of mitochondrial
death pathway and induction of endothelial apoptosis [45,
156]. Chen et al. results suggest that the cytotoxicity of
CdTe QDs not only comes from the release of Cd2+ ions
but also intracellular distribution of QDs in cells and the
associated nanoscale effects [157]. In other side, Ye et al.
shown that acute toxicity of these QDs in vivo can be
minimal. They demonstrated that rhesus macaques injected
with phospholipid micelle-encapsulated CdSe/CdS/ZnS
QDs, blood and biochemical markers remained within
normal ranges following treatment, and histology of major
organs after 90 days showed no abnormalities [158]. In the
other study, histological and biochemical analysis, and body
weight measurement demonstrate that there is no overt
toxicity of QDs in mice even at long-time exposure time
[159]. Table 8 demonstrated more results for toxicity of QDs.

11

Conclusion

In this review, we discussed three methods for synthesis of


heavy metal chalcogenide-based QDs for use in biomedical
eld. Also, we discussed new methods for synthesis of
bioapplicable QDs. We briey discussed the applications,
toxicity, photostability of QDs and surface engineering of
QDs for use in biology. The most popular method of QDs
synthesis is organometallic synthesis. The high reaction
temperature in this method ( >150350C) has two major
advantages: facilitates the removal of crystalline defects and
allows improvement in the photoluminescence. Size
71

& The Institution of Engineering and Technology 2014

www.ietdl.org
distribution of QDs prepared by this method can be easily
controlled by alerting temperature or reaction time. CdSe,
CdS or CdTe QDs synthesis with organometallic has a
comparatively low QY (brightness), usually less than 10%,
requiring a shell of a high band-gap semiconductor, such as
CdS or ZnS to be epitaxially grown around the core which
increases the QY up to 80%. This layer moreover protects
the core from oxidation and prevents leaching of the Cd/Se.
The main drawback of this technique is that the QDs
require the ligand exchange or encapsulation to make them
compatible in biological solutions. Direct aqueous synthesis
of QDs by applying different thiol groups as stabilising
agents provides an effective alternative to widely used
synthetic routes in highly boiling organic solvents.
Advantages of this method compared of organometallic are
ease and high reproducibility, low cost, vast scale and
synthesised QDs with this method can be precipitated,
washed and reserved in the dry state under ambient
conditions as long as two years being stable and dissolvable
in water and this method is environment-friendly. In this
method the ligands used during formation of QDs become
biocompatible surface ligands and do not need an exchange
process. The organometallic method and water-based
syntheses are two successful routes for produce the highly
uorescent heavy metal chalcogenide-based QDs. However,
the recent methods involve highly toxic chemicals, such as
TOP or TOPO, high temperatures and non-polar solvents in
the synthesis procedure and limited their applications in
biomedical elds. Albeit biosynthesis of QDs are regarded
as safe, cost-effective, sustainable and eco-friendly
processes, they also have some disadvantages in culturing
of microbes, which is time-consuming and difcult in
providing better control over size distribution, shape and
crystallinity. QDs prepared by this method are also not
monodispersible and the rate of production is slow. These
are the problems in synthesis of QDs with microorganisms,
but the information obtained from strain selection,
optimising the conditions like pH, incubation temperature
and time, concentration of metal ions, and the amount of
biological material has come up to give hope in
achievement of these approaches in large scale and for
biomedical applications. In recent years, scientists have
worked on novel methods for the synthesis of QDs with
suitable properties for use in medical. The new techniques
are often based on improved aqueous synthesis and
biosynthesis of QDs. These methods are often used CdCl2
as a source of cadmium and short chain thiols as stabilising
agents and they could synthesis QDs with advantages such
as low toxicity, better biocompatibility, and short synthesis
period, environmental friendly and improved photostability.

12

Future prospects

According to unique properties of QDs, they are suitable


alternatives to conventional organic uorophors for
labelling cells, investigating cellular process, and for many
other imaging applications. Although current synthesis
methods of QDs somewhat capable to prepare appropriate
QDs for utilise in biology, but to overcome the present
problems in QDs synthesis, in the near future, there are
several areas of research that are particularly promising and
should be paid enough attention to:
1. Improvement of aqueous route and synthesis QDs with
enhanced QY and narrower size distribution.
72

& The Institution of Engineering and Technology 2014

2. Changing the conditions of reaction media in synthesis of


QDs that cause to produce QDs with improved characteristics.
3. Use of safe solvent and stabiliser in QDs synthesis
methods.
4. Development of novel type of QDs without heavy metals
such as cadmium.
5. With changing the condition of reaction such as heating
temperature and heating time, pH, the amount of precursors,
reactant Concentration and can be produced QDs with
suitable properties for use in biology and medicine.
6. Future research on microbes-mediated biological synthesis
of QDS: using different species of microorganisms that live in
harsh conditions and changing the growing parameter in
culture media can produce improved QDs. In addition, this
method has some challenges such as scaling up of the
synthesis to obtain large amount of QDs, improved control
over size and shape and understanding the synthesis
mechanism at the molecular level, which nally may help
in providing better control over size, shapes and
crystallinity in the future.

13

References

1 Murray, C.B., Kagan, C.R., Bawendi, M.G.: Synthesis and


characterization of monodisperse nanocrystals and close-packed
nanocrystal assemblies, Ann. Rev. Mater. Sci., 2000, 30, (1),
pp. 545610
2 Zrazhevskiy, P., Sena, M., Gao, X.: Designing multifunctional
quantum dots for bioimaging, detection, and drug delivery, Chem.
Soc. Rev., 2010, 39, (11), pp. 43264354
3 Alivisatos, A.P.: Semiconductor clusters, nanocrystals, and quantum
dots, Science, 1996, 271, (5251), pp. 933937
4 Jain, P.K., Huang, X., El-Sayed, I.H., El-Sayed, M.A.: Noble metals
on the nanoscale: optical and photothermal properties and some
applications in imaging, sensing, biology, and medicine, Acc. Chem.
Res., 2008, 41, (12), pp. 15781586
5 Park, J., Joo, J., Kwon, S.G., Jang, Y., Hyeon, T.: Synthesis of
monodisperse spherical nanocrystals, Angew. Chem. (Int. ed Engl.),
2007, 46, (25), pp. 46304660
6 Michalet, X., Pinaud, F.F., Bentolila, L.A., et al.: Quantum Dots for
live cells, in vivo imaging, and diagnostics, Science, 2005, 307,
(5709), pp. 538544
7 Alivisatos, P.: The use of nanocrystals in biological detection, Nat.
Biotech., 2004, 22, (1), pp. 4752
8 Talapin, D.V., Lee, J.S., Kovalenko, M.V., Shevchenko, E.V.:
Prospects of colloidal nanocrystals for electronic and optoelectronic
applications, Chem. Rev., 2010, 110, (1), pp. 389458
9 Daniel, M.C., Astruc, D.: Gold nanoparticles: assembly,
supramolecular chemistry, quantum-size-related properties, and
applications toward biology, catalysis, and nanotechnology, Chem.
Rev., 2004, 104, (1), pp. 293346
10 Medintz, I.L., Uyeda, H.T., Goldman, E.R., Mattoussi, H.: Quantum
dot bioconjugates for imaging, labelling and sensing, Nat. Mater.,
2005, 4, (6), pp. 435446
11 Somers, R.C., Bawendi, M.G., Nocera, D.G.: CdSe nanocrystal based
chem-/bio- sensors, Chem. Soc. Rev., 2007, 36, (4), pp. 579591
12 Agasti, S.S., Rana, S., Park, M.H., Kim, C.K., You, C.C., Rotello, V.
M.: Nanoparticles for detection and diagnosis, Adv. Drug Deliv. Rev.,
2010, 62, (3), pp. 316328
13 Sperling, R.A., Parak, W.J.: Surface modication, functionalization
and bioconjugation of colloidal inorganic nanoparticles, Phil. Trans.
A, Math. Phys. Eng. Sci., 2010, 368, (1915), pp. 13331383
14 Joo, J., Na, H.B., Yu, T., et al.: Generalized and facile synthesis of
semiconducting metal sulde nanocrystals, J. Am. Chem. Soc.,
2003, 125, (36), pp. 1110011105
15 Gao, X., Yang, L., Petros, J.A., Marshall, F.F., Simons, J.W., Nie, S.:
In vivo molecular and cellular imaging with quantum dots, Curr.
Opin. Biotechnol., 2005, 16, (1), pp. 6372
16 Brus, L.E.: Electronelectron and electron-hole interactions in small
semiconductor crystallites: the size dependence of the lowest excited
electronic state, J. Chem. Phys., 1984, 80, (9), pp. 44034409
17 Zhang, H., Wang, L., Xiong, H., Hu, L., Yang, B., Li, W.:
Hydrothermal synthesis for high-quality CdTe nanocrystals, Adv.
Mater., 2003, 15, (20), pp. 17121715
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
18 Yu, W.W., Chang, E., Drezek, R., Colvin, V.L.: Water-soluble
quantum dots for biomedical applications, Biochem. Biophys. Res.
Commun., 2006, 348, (3), pp. 781786
19 Gao, X., Cui, Y., Levenson, R.M., Chung, L.W.K., Nie, S.: In vivo
cancer targeting and imaging with semiconductor quantum dots,
Nat. Biotechnol., 2004, 22, (8), pp. 969976
20 Sapsford, K., Pons, T., Medintz, I., Mattoussi, H.: Biosensing with
luminescent semiconductor quantum dots, Sensors, 2006, 6, (8),
pp. 925953
21 Soo Choi, H., Liu, W., Misra, P., et al.: Renal clearance of quantum
dots, Nat. Biotechnol., 2007, 25, (10), pp. 11651170
22 Gao, J., Chen, K., Xie, R., et al.: In vivo tumor-targeted uorescence
imaging using near-infrared non-cadmium quantum dots, Bioconjug.
Chemis., 2010, 21, (4), pp. 604609
23 Fu, A., Gu, W., Larabell, C., Alivisatos, A.P.: Semiconductor
nanocrystals for biological imaging, Curr. Opin. Neurobiol., 2005,
15, (5), pp. 568575
24 Ballou, B., Lagerholm, B.C., Ernst, L.A., Bruchez, M.P., Waggoner,
A.S.: Noninvasive imaging of quantum dots in mice, Bioconjug.
Chem., 2004, 15, (1), pp. 7986
25 Smith, B.R., Cheng, Z., De, A., Koh, A.L., Sinclair, R., Gambhir, S.S.:
Real-time intravital imaging of RGD-quantum dot binding to luminal
endothelium in mouse tumor neovasculature, Nano Lett., 2008, 8, (9),
pp. 25992606
26 Park, J., Dvoracek, C., Lee, K.H., et al.: CuInSe/ZnS core/shell NIR
quantum dots for biomedical imaging, Small, 2011, 7, (22),
pp. 314852
27 Jaiswal, J.K., Goldman, E.R., Mattoussi, H., Simon, S.M.: Use of
quantum dots for live cell imaging, Nat Meth, 2004, 1, (1), pp. 7378
28 Chang, Y.-P., Pinaud, F., Antelman, J., Weiss, S.: Tracking
bio-molecules in live cells using quantum dots, J. Biophotonics,
2008, 1, (4), pp. 287298
29 Cherry, R.J.: Keeping track of cell surface receptor, Trends Cell Biol.,
1992, 2, (8), pp. 242244
30 Saxton, M.J., Jacobson, K.: Single-particle tracking: applications to
membrane dynamics, Annu. Rev. Biophys. Biomol. Struct., 1997, 26,
pp. 373399
31 Deerinck, T.J.: The application of uorescent quantum dots to
confocal, multiphoton, and electron microscopic imaging, Toxicol.
Pathol., 2008, 36, (1), pp. 112116
32 Bruchez, M., Moronne, M., Gin, P., Weiss, S., Alivisatos, A.P.:
Semiconductor Nanocrystals as Fluorescent Biological Labels,
Science, 1998, 281, (5385), pp. 20132016
33 Coe, S., Woo, W.-K., Bawendi, M., Bulovic, V.: Electroluminescence
from single monolayers of nanocrystals in molecular organic devices,
Nature, 2002, 420, (6917), pp. 800803
34 Klimov, V.I., Mikhailovsky, A.A., Xu, S., et al.: Optical gain and
stimulated emission in nanocrystal quantum dots, Science, 2000,
290, (5490), pp. 314317
35 Duan, X., Niu, C., Sahi, V., et al.: High-performance thin-lm
transistors using semiconductor nanowires and nanoribbons, Nature,
2003, 425, (6955), pp. 274278
36 Gur, I., Fromer, N.A., Geier, M.L., Alivisatos, A.P.: Air-stable
all-inorganic nanocrystal solar cells processed from solution,
Science, 2005, 310, (5747), pp. 462465
37 Liu, J., Tanaka, T., Sivula, K., Alivisatos, A.P., Frchet, J.M.J.:
Employing end-functional polythiophene to control the morphology
of nanocrystal polymer composites in hybrid solar cells, J. Am.
Chem. Soc., 2004, 126, (21), pp. 65506551
38 Cai, W., Shin, D.-W., Chen, K., et al.: Peptide-labeled near-infrared
quantum dots for imaging tumor vasculature in living subjects,
Nano Lett., 2006, 6, (4), pp. 669676
39 Wang, C., Jiang, Y., Chen, L., Li, S., Li, G., Zhang, Z.: Temperature
dependence of optical properties and size tunability CdSe quantum
dots via non-TOP synthesis, Mater. Chem. Phys., 2009, 116, (23),
pp. 388391
40 Sharma, S.N., Kumar, U., Singh, V.N., Mehta, B.R., Kakkar, R.:
Surface modication of CdSe quantum dots for biosensing
applications: role of ligands, Thin Solid Films, 2010, 519, (3),
pp. 12021212
41 Reiss, P., Protire, M., Li, L.: Core/shell semiconductor nanocrystals,
Small, 2009, 5, (2), pp. 154168
42 Rosenthal, S.J., Chang, J.C., Kovtun, O., McBride, J.R., Tomlinson, I.
D.: Biocompatible quantum dots for biological applications, Chem.
Biol., 2011, 18, (1), pp. 1024
43 Jin, S., Hu, Y., Gu, Z., Liu, L., Wu, H.-C.: Application of quantum
dots in biological imaging, J. Nanomater., 2011, 2011, pp. 113
44 Eychmller, A., Rogach, A.L.: Chemistry and photophysics of
thiol-stabilized II-VI semiconductor nanocrystals, Pure Appl. Chem.,
2000, 72, pp. 179188
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

45 Valizadeh, A., Mikaeili, H., Zarghami, N., et al.: Quantum dots:


synthesis, bioapplications, and toxicity, Nanoscale Res. Lett., 2012,
7, (1), p. 480
46 Arnot, H.E.G., Watt, M., Sotomayor-Torres, C.M., et al.:
Photoluminescence of overgrown GaAs-GaAlAs quantum dots,
Superlattices Microstructures, 1989, 5, (3), pp. 459463
47 Zhu, Z.J., Yeh, Y.C., Tang, R., et al.: Stability of quantum dots in live
cells, Nat. Chem., 2011, 3, (12), pp. 963968
48 Ma, Q.F., Chen, J.Y., Wang, P.N., Yue, Y., Dai, N.: Photostability
comparison of CdTe and CdSe/CdS/ZnS quantum dots in living cells
under single and two-photon excitations, J. Lumin., 2011, 131, (11),
pp. 22672272
49 Manner, V.W., Koposov, A.Y., Szymanski, P., Klimov, V.I., Sykora,
M.: Role of solventoxygen ion pairs in photooxidation of cdse
nanocrystal quantum dots, ACS Nano, 2012, 6, (3), pp. 23712377
50 Peng, X., Thessing, J.: Controlled synthesis of high quality
semiconductor nanocrystals, in Peng, X., Mingos, D. (Eds.):
Semiconductor nanocrystals and silicate nanoparticles (Springer,
Berlin, Heidelberg, 2005), pp. 79119
51 Ekimov, A.I., Onushchenko, A.A., Tsekhomskii, V.A.: Exciton
absorption by copper(I) chloride crystals in a glassy matrix, Fizika i
Khimiya Stekla, 1980, 6, p. 511
52 Ekimov, A.: Growth and optical properties of semiconductor
nanocrystals in a glass matrix, J. Lumin., 1996, 70, (16), pp. 120
53 Rossetti, R., Nakahara, S., Brus, L.E.: Quantum size effects in the
redox potentials, resonance Raman spectra, and electronic spectra of
CdS crystallites in aqueous solution, J. Chem. Phys., 1983, 79, (2),
pp. 10861088
54 He, R., Gu, H.: Synthesis and characterization of mondispersed CdSe
nanocrystals at lower temperature, Colloids Surf. A, Physicochem.
Eng. Aspects, 2006, 272, (12), pp. 111116
55 Bakar, N.A., Umar, A.A., Aziz, T.H.T., et al., (Eds.): Synthesis of
CdSe quantum dots: effect of surfactant on the photoluminescence
property. Semiconductor Electronics, 2008 ICSE 2008 IEEE Int.
Conf., 2527 November 2008
56 Yin, Y., Alivisatos, A.P.: Colloidal nanocrystal synthesis and the
organic-inorganic interface, Nature, 2005, 437, (7059), pp. 664670
57 Byers, R.J., Hitchman, E.R.: Quantum dots brighten biological
imaging, Prog. Histochem. Cytochem., 2011, 45, (4), pp. 201237
58 Steigerwald, M.L., Brus, L.E.: Semiconductor crystallites: a class of
large molecules, Acc. Chem. Res., 1990, 23, (6), pp. 183188
59 Murray, C.B., Norris, D.J., Bawendi, M.G.: Synthesis and
characterization of nearly monodisperse CdE (E = sulfur, selenium,
tellurium) semiconductor nanocrystallites, J. Am. Chem. Soc., 1993,
115, (19), pp. 87068715
60 Clarke, S.J.: Synthesis, biological targeting and photophysics of
quantum dots (McGill University, 2008)
61 Stuczynski, S.M., Brennan, J.G., Steigerwald, M.L.: Formation of
metal-chalcogen bonds by the reaction of metal-alkyls with silyl
chalcogenides, Inorg. Chem., 1989, 28, (25), pp. 44314432
62 Steigerwald, M.L.: Clusters as small solids, Polyhedron, 1994, 13,
(8), pp. 12451252
63 Guo, L.: Synthesis and characterization of II-VI and IV-VI colloidal
semiconductor quantum dots (University of Rochester, New York,
2008)
64 Crouch, D., Norager, S., OBrien, P., Park, J.H., Pickett, N.: New
synthetic routes for quantum dots, Phil. Trans. Ser. A, Math. Phys.
Eng. Sci., 2003, 361, (1803), pp. 297310, see Discussion
65 Prezhdo, O.V., Rossky, P.J.: Quantum decoherence and short time
solvent response in condensed phase non-adiabatic processes, Phys.
Rev. Lett., 1998, 81, (5294), pp. 52945297
66 Cingarapu, S., Yang, Z., Sorensen, C.M., Klabunde, K.J.: Synthesis of
CdSe/ZnS and CdTe/ZnS quantum dots: rened digestive ripening,
J. Nanomater., 2012, 2012, pp. 1
67 Hambrock, J., Birkner, A., Fischer, R.A.: Synthesis of CdSe
nanoparticles using various organometallic cadmium precursors,
J. Mater. Chem., 2001, 11, (12), pp. 31973201
68 Talapin, D.V., Mekis, I., Gtzinger, S., Kornowski, A., Benson, O.,
Weller, H.: CdSe/CdS/ZnS and CdSe/ZnSe/ZnS core shell shell
nanocrystals, J. Phys. Chem. B, 2004, 108, (49), pp. 1882618831
69 Bullen, C.R., Mulvaney, P.: Nucleation and growth kinetics of CdSe
nanocrystals in octadecene, Nano Lett., 2004, 4, (12), pp. 23032307
70 Yu, W.W., Peng, X.: Formation of high-quality CdS and other IIVI
semiconductor nanocrystals in noncoordinating solvents: tunable
reactivity of monomers, Angew. Chem. Int. Ed., 2002, 41, (13),
pp. 23682371
71 Rogach, A.L.: Semiconductor nanocrystal quantum dots: synthesis,
assembly, spectroscopy and applications (Springer, 2008)
72 Dabbousi, B.O., Rodriguez-Viejo, J., Mikulec, F.V., et al.: (CdSe)ZnS
core shell quantum dots: synthesis and characterization of a size
73

& The Institution of Engineering and Technology 2014

www.ietdl.org
73
74
75
76

77
78

79

80

81
82

83
84
85
86
87
88
89
90
91

92

93

94
95

96

series of highly luminescent nanocrystallites, J. Phys. Chem. B, 1997,


101, (46), pp. 94639475
Qu, L., Peng, Z.A., Peng, X.: Alternative routes toward high quality
CdSe nanocrystals, Nano Lett., 2001, 1, (6), pp. 333337
Talapin, D.V., Haubold, S., Rogach, A.L., Kornowski, A., Haase, M.,
Weller, H.: A novel organometallic synthesis of highly luminescent
CdTe nanocrystals, J. Phys. Chem. B, 2001, 105, (12), pp. 22602263
Peng, Z.A., Peng, X.: Formation of high-quality CdTe, CdSe, and CdS
nanocrystals using CdO as precursor, J.. Am. Chem. Soc., 2000, 123,
(1), pp. 183184
Subashini, A., Karl, M.K., Ammar, A., et al.: The use of heat transfer
uids in the synthesis of high-quality CdSe quantum dots, core/shell
quantum dots, and quantum rods, Nanotechnology, 2005, 16, (10),
pp. 2000
Cao, Y.C., Wang, J.: One-pot synthesis of high-quality zinc-blende
CdS nanocrystals, J. Am. Chem. Soc., 2004, 126, (44),
pp. 1433614337
Talapin, D.V., Rogach, A.L., Kornowski, A., Haase, M., Weller, H.:
Highly luminescent monodisperse CdSe and CdSe/ZnS nanocrystals
synthesized in a hexadecylamine trioctylphosphine oxide
trioctylphospine mixture, Nano Lett., 2001, 1, (4), pp. 207211
Talapin, D.V., Rogach, A.L., Shevchenko, E.V., Kornowski, A.,
Haase, M., Weller, H.: Dynamic distribution of growth rates within
the ensembles of colloidal II-VI and III-V semiconductor
nanocrystals as a factor governing their photoluminescence
efciency, J. Am. Chem. Soc., 2002, 124, (20), pp. 57825790
Asokan, S., Krueger, K.M., Alkhawaldeh, A., et al.: The use of heat
transfer uids in the synthesis of high-quality CdSe quantum dots,
core/shell quantum dots, and quantum rods, Nanotechnology, 2005,
16, (10), pp. 20002011
Sapra, S., Rogach, A.L., Feldmann, J.: Phosphine-free synthesis of
monodisperse CdSe nanocrystals in olive oil, J. Mater. Chem.,
2006, 16, (33), pp. 33913395
Nag, A., Sapra, S., Chakraborty, S., Basu, S., Sarma, D.D.: Synthesis
of CdSe nanocrystals in a noncoordinating solvent: effect of reaction
temperature on size and optical properties, J. Nanosci.
Nanotechnol., 2007, 7, (6), pp. 19651968
Kumar, C.S.S.R.: Semiconductor nanomaterials (John Wiley & Sons,
2010)
Smith, A.M., Duan, H., Mohs, A.M., Nie, S.: Bioconjugated quantum
dots for in vivo molecular and cellular imaging, Adv. Drug Deliv. Rev.,
2008, 60, (11), pp. 12261240
Cassette, E., Helle, M., Bezdetnaya, L., Marchal, F., Dubertret, B.,
Pons, T.: Design of new quantum dot materials for deep tissue
infrared imaging, Adv. Drug Deliv. Rev., 2012
Mattoussi, H., Palui, G., Na, H.B.: Luminescent quantum dots as
platforms for probing in vitro and in vivo biological processes, Adv.
Drug Deliv. Rev., 2012, 64, (2), pp. 138166
Wang, Y., Chen, L.: Quantum dots, lighting up the research and
development of nanomedicine, Nanomed.: Nanotechnol. Biol. Med.,
2011, 7, (4), pp. 385402
Peng, X.: Green chemical approaches toward high-quality
semiconductor nanocrystals, Chem. A, Eur. J., 2002, 8, (2),
pp. 334339
Shan Jin, Y.H., Gu, Z., Liu, L., Wu, H.-C.: Application of quantum
dots in biological imaging, J. Nanomater., 2011, 2011, pp. 113
Dahl, J.A., Maddux, B.L., Hutchison, J.E.: Toward greener
nanosynthesis, Chem. Rev., 2007, 107, (6), pp. 22282269
Mattoussi, H., Mauro, J.M., Goldman, E.R., et al.: Self-assembly of
CdSe ZnS quantum dot bioconjugates using an engineered
recombinant protein, J. Am. Chem. Soc., 2000, 122, (49),
pp. 1214212150
Vossmeyer, T., Katsikas, L., Giersig, M., et al.: CdS nanoclusters:
synthesis, characterization, size dependent oscillator strength,
temperature shift of the excitonic transition energy, and reversible
absorbance shift, J. Phys. Chem., 1994, 98, (31), pp. 76657673
Rogach, A.L., Kornowski, A., Gao, M., Eychmller, A., Weller, H.:
Synthesis and characterization of a size series of extremely small
thiol-stabilized CdSe nanocrystals, J. Phys. Chem. B, 1999, 103,
(16), pp. 30653069
Gaponik, N., Talapin, D.V., Rogach, A.L., et al.: Thiol-capping of
CdTe nanocrystals: an alternative to organometallic synthetic
routes, J. Phys. Chem. B, 2002, 106, (29), pp. 71777185
Rogach, A.L., Katsikas, L., Kornowski, A., Su, D., Eychmller, A.,
Weller, H.: Synthesis and characterization of thiol-stabilized CdTe
nanocrystals, Berichte der Bunsengesellschaft fr physikalische
Chemie, 1996, 100, (11), pp. 17721778
Rogach, A.L., Franzl, T., Klar, T.A., et al.: Aqueous synthesis of
thiol-capped CdTe nanocrystals: state-of-the-Art, J. Phys. Chem. C,
2007, 111, (40), pp. 1462814637

74

& The Institution of Engineering and Technology 2014

97 Zhang, Y., Clapp, A.: Overview of stabilizing ligands for


biocompatible quantum dot nanocrystals, Sensors, 2011, 11, (12),
pp. 1103611055
98 Chen, H.M., Huang, X.F., Xu, L., Xu, J., Chen, K.J., Feng, D.:
Self-assembly and photoluminescence of CdS-mercaptoacetic
clusters with internal structures, Superlattices Microstructures, 2000,
27, (1), pp. 15
99 Weng, J., Song, X., Li, L., et al.: Highly luminescent CdTe quantum
dots prepared in aqueous phase as an alternative uorescent probe for
cell imaging, Talanta, 2006, 70, (2), pp. 397402
100 Choi, S.Y., Shim, J.P., Kim, D.S., Kim, T.Y., Suh, K.S.: Aqueous
synthesis of CdTe quantum dot using dithiol-functionalized ionic
liquid, J. Nanomater., 2012, 2012, pp. 10
101 Li, L., Qian, H., Fang, N., Ren, J.: Signicant enhancement of the
quantum yield of CdTe nanocrystals synthesized in aqueous phase
by controlling the pH and concentrations of precursor solutions,
J. Lumin., 2006, 116, (12), pp. 5966
102 Zhao, D., He, Z., Chan, W.H., Choi, M.M.F.: Synthesis and
characterization of high-quality water-soluble near-infrared-emitting
CdTe/CdS quantum dots capped by N-Acetyl-l-cysteine via
hydrothermal method, J. Phys. Chem. C, 2008, 113, (4),
pp. 12931300
103 Bao, H., Hao, N., Yang, Y., Zhao, D.: Biosynthesis of biocompatible
cadmium telluride quantum dots using yeast cells, Nano Res., 2010, 3,
(7), pp. 481489
104 Narayanan, K.B., Sakthivel, N.: Biological synthesis of metal
nanoparticles by microbes, Adv. Colloid Interface Sci., 2010, 156,
(12), pp. 113
105 Gardea-Torresdey, J.L., Parsons, J.G., Gomez, E., et al.: Formation
and growth of Au nanoparticles inside live alfalfa plants, Nano
Lett., 2002, 2, (4), pp. 397401
106 Kumar, S.A., Ansary, A.A., Ahmad, A., Khan, M.I.: Extracellular
biosynthesis of CdSe quantum dots by the fungus, Fusarium
oxysporum, J. Biomed. Nanotechnol., 2007, 3, (2), pp. 190194
107 Roane, T.M., Pepper, I.L.: Microbial responses to environmentally
toxic cadmium, Microb. Ecol., 1999, 38, (4), pp. 358364
108 Bruins, M.R., Kapil, S., Oehme, F.W.: Microbial resistance to metals
in the environment, Ecotoxicol. Environ. Safety, 2000, 45, (3),
pp. 198207
109 Silver, S.: Plasmid-determined metal resistance mechanisms: range
and overview, Plasmid, 1992, 27, (1), pp. 13
110 Laddaga, R.A., Bessen, R., Silver, S.: Cadmium-resistant mutant of
Bacillus subtilis 168 with reduced cadmium transport, J. Bacteriol.,
1985, 162, pp. 11061110
111 Andreoni, V., Finoli, C., Manfrin, P., Pelosi, M., Vecchio, A.: Studies
on the accumulation of cadmium by a strain of Proteus mirabilis,
FEMS Microbiol. Lett., 1991, 85, (3), pp. 183191
112 Mullen, M.D., Wolf, D.C., Ferris, F.G., Beveridge, T.J., Flemming, C.
A., Bailey, G.W.: Bacterial sorption of heavy metals, Appl. Environ.
Microbiol., 1989, 55, (12), pp. 31433149
113 Aiking, H., Kok, K., van Heerikhuizen, H., van t Riet, J.: Adaptation
to cadmium by Klebsiella aerogenes growing in continuous culture
proceeds mainly via formation of cadmium sulde, Appl. Environ.
Microbiol., 1982, 44, (4), pp. 938944
114 Aiking, H., Stijnman, A., van Garderen, C., van Heerikhuizen, H., van
t Riet, J.: Inorganic phosphate accumulation and cadmium
detoxication in Klebsiella aerogenes NCTC 418 growing in
continuous culture, Appl. Environ. Microbiol., 1984, 47, (2),
pp. 374377
115 Macaskie, L.E., Dean, A.C.: Cadmium accumulation by a Citrobacter
sp, J. Gen. Microbiol., 1984, 130, (1), pp. 5362
116 Kurek, E., Francis, A.J., Bollag, J.M.: Immobilization of cadmium by
microbial extracellular products, Arch. Environ. Contamin. Toxicol.,
1991, 21, (1), pp. 106111
117 Nies, D.H.: Resistance to cadmium, cobalt, zinc, and nickel in
microbes, Plasmid, 1992, 27, (1), pp. 1728
118 Ahmad, A., Mukherjee, P., Mandal, D., et al.: Enzyme mediated
extracellular synthesis of CdS nanoparticles by the fungus, Fusarium
oxysporum, J. Am. Chem. Soc., 2002, 124, (41), pp. 1210812119
119 Bai, H.J., Zhang, Z.M., Guo, Y., Yang, G.E.: Biosynthesis of
cadmium sulde nanoparticles by photosynthetic bacteria
Rhodopseudomonas palustris, Colloids Surf. B, Biointerfaces,
2009, 70, (1), pp. 142146
120 Mi, C., Wang, Y., Zhang, J., et al.: Biosynthesis and characterization
of CdS quantum dots in genetically engineered Escherichia coli,
J. Biotechnol., 2011, 153, (34), pp. 125132
121 Bao, H., Lu, Z., Cui, X., et al.: Extracellular microbial synthesis of
biocompatible CdTe quantum dots, Acta Biomater., 2010, 6, (9),
pp. 35343541
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

www.ietdl.org
122 Narayanan, K.B., Sakthivel, N.: Biological synthesis of metal
nanoparticles by microbes, Adv. Colloid Interface Sci., 2010, 156,
(12), pp. 113
123 Sweeney, R.Y., Mao, C., Gao, X., et al.: Bacterial biosynthesis of
cadmium sulde nanocrystals, Chem. Biol., 2004, 11, (11),
pp. 15531559
124 Dameron, C.T., Reese, R.N., Mehra, R.K., et al.: Biosynthesis of
cadmium sulphide quantum semiconductor crystallites, Nature,
1989, 338, (6216), pp. 596597
125 Kowshik, M., Deshmukh, N., Vogel, W., Urban, J., Kulkarni, S.K.,
Paknikar, K.M.: Microbial synthesis of semiconductor CdS
nanoparticles, their characterization, and their use in the fabrication
of an ideal diode, Biotechnol. Bioeng., 2002, 78, (5), pp. 583588
126 Cunningham, D.P., Lundie, L.L. Jr.: Precipitation of cadmium by
Clostridium thermoaceticum, Appl. Environ. Microbiol., 1993, 59,
(1), pp. 714
127 Holmes, J.D., Richardson, D.J., Saed, S., Evans-Gowing, R., Russell,
D.A., Sodeau, J.R.: Cadmium-specic formation of metal sulde
Q-particles by Klebsiella pneumoniae, Microbiology (Reading,
England), 1997, 143, (Pt 8), pp. 25212530
128 Holmes, J.D., Smith, P.R., Evans-Gowing, R., Richardson, D.J.,
Russell, D.A., Sodeau, J.R.: Energy-dispersive X-ray analysis of the
extracellular cadmium sulde crystallites of Klebsiella aerogenes,
Arch. Microbiol., 1995, 163, (2), pp. 143147
129 Li, X., Chen, S., Hu, W., et al.: In situ synthesis of CdS nanoparticles
on bacterial cellulose nanobers, Carbohydrate Polymers, 2009, 76,
(4), pp. 509512
130 Bao, Y., Li, J., Wang, Y., et al.: Preparation of water soluble CdSe and
CdSe/CdS quantum dots and their uses in imaging of cell and blood
capillary, Opt. Mater., 2012, 34, (9), pp. 15881592
131 Prez-Donoso, J.M., Monrs, J.P., Bravo, D., et al.: Biomimetic, mild
chemical synthesis of CdTe-GSH quantum dots with improved
biocompatibility, PLoS ONE, 2012, 7, (1), pp. e30741
132 Ghows, N., Entezari, M.H.: A novel method for the synthesis of CdS
nanoparticles without surfactant, Ultrason. Sonochem., 2011, 18, (1),
pp. 269275
133 Zhao, M.-X., Su, H., Mao, Z.-W., Ji, L.-N.: Synthesis,
biocompatibility and luminescence properties of quantum dots
conjugated with amino acid-functionalized -cyclodextrin,
J. Lumin., 2012, 132, (1), pp. 1622
134 Qiu, H.K., Shen, Y., Wang, L.J., Zhang, J.C., Qin, K.F., (Eds.):
Synthesis of high-performance aqueous CdSe quantum dots based
on combination of Se source as vapor-phase and hydrothermal
method (Trans Tech. Publ, 2011)
135 de Azevedo, W.M., Menezes, F.D.: A new and straightforward
synthesis route for preparing Cds quantum Dots, J. Lumin., 2012,
132, (7), pp. 17401743
136 Liu, X., Jiang, Y., Lan, X., et al.: Synthesis of high quality and
stability CdS quantum dots with overlapped nucleation-growth
process in large scale, J. Colloid Interface Sci., 2011, 354, (1),
pp. 1522
137 Entezari, M.H., Ghows, N.: Micro-emulsion under ultrasound
facilitates the fast synthesis of quantum dots of CdS at low
temperature, Ultrason. Sonochem., 2011, 18, (1), pp. 127134
138 Aboulaich, A., Billaud, D., Abyan, M., et al.: One-pot noninjection
route to CdS quantum dots via hydrothermal synthesis, ACS Appl.
Mater. Interfaces, 2012, 4, (5), pp. 25612569
139 Rong, X.L., Zhao, Q., Tao, G.H.: Aqueous synthesis of CdSe and
CdSe/CdS quantum dots with controllable introduction of Se and S
sources, Chin. Chem. Lett., 2012
140 Saran, A.D., Bellare, J.R.: Green engineering for large-scale synthesis
of water-soluble and bio-taggable CdSe and CdSeCdS quantum dots
from microemulsion by double-capping, Colloids Surf. A,
Physicochem. Eng. Aspects, 2010, 369, (1), pp. 165175
141 Yang, P., Ando, M., Taguchi, T., Murase, N.: Highly luminescent
CdSe/Cd x Zn1x S quantum dots with narrow spectrum and widely
tunable wavelength, J. Phys. Chem. C, 2011, 115, (30),
pp. 1445514460
142 Han, H., Sheng, Z., Liang, J.: A novel method for the preparation of
water-soluble and small-size CdSe quantum dots, Mater. Lett., 2006,
60, (29), pp. 37823785
143 Wang, Q., Ye, F., Fang, T., et al.: Bovine serum albumin-directed
synthesis of biocompatible CdSe quantum dots and bacteria
labeling, J. Colloid Interface Sci., 2011, 355, (1), pp. 914
144 Wang, Q., Li, S., Liu, P., Min, X.: Bio-templated CdSe quantum dots
green synthesis in the functional protein, lysozyme, and biological
activity investigation, Mater. Chem. Phys., 2012, 137, (2),
pp. 580585
145 Wang, Y., Mo, Y., Zhou, L.: Synthesis of CdSe quantum dots using
selenium dioxide as selenium source and its interaction with pepsin,
IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976
doi: 10.1049/iet-nbt.2012.0028

146
147
148
149

150
151
152
153

154
155

156
157
158
159

160
161
162

163
164
165
166
167
168
169
170
171

Spectrochim. Acta A, Mol. Biomol. Spectrosc., 2011, 79, (5),


pp. 13111315
Chen, X.F., Zhou, M., Chang, Y.P., Ren, C.L., Chen, H.L., Chen, X.G.:
Novel synthesis of -cyclodextrin functionalized CdTe quantum dots
as luminescent probes, Appl. Surf. Sci., 2012, 267, pp. 491496
Liu, M., Zhao, H., Chen, S., Wang, H., Quan, X.: Photochemical
synthesis of highly uorescent CdTe quantum dots for onoffon
detection of Cu (II) ions, Inorg. Chim. Acta, 2012
Li, M., Zhou, H., Zhang, H., et al.: Preparation and purication of
l-cysteine capped CdTe quantum dots and its self-recovery of
degenerate uorescence, J. Lumin., 2010, 130, (10), pp. 19351940
Yu, Y., Xu, L., Chen, J., et al.: Hydrothermal synthesis of GSH-TGA
co-capped CdTe quantum dots and their application in labeling
colorectal cancer cells, Colloids Surf. B, Biointerfaces, 2012, 95,
pp. 247253
Pei, J., Zhu, H., Wang, X., Zhang, H., Yang, X.: Synthesis of
cysteamine-coated CdTe quantum dots and its application in mercury
(II) detection (Highlighted), Anal. Chim. Acta, 2012, 757, pp. 6368
Wang, J., Han, H.: Hydrothermal synthesis of high-quality type-II
CdTe/CdSe quantum dots with near-infrared uorescence, J. Colloid
Interface Sci., 2010, 351, (1), pp. 8387
Liu, Y.F., Yu, J.S.: In situ synthesis of highly luminescent
glutathione-capped CdTe/ZnS quantum dots with biocompatibility,
J. Colloid Interface Sci., 2010, 351, (1), pp. 19
Zhu, Y., Li, Z., Chen, M., Cooper, H.M., Lu, G.Q., Xu, Z.P.: One-pot
preparation of highly uorescent cadmium telluride/cadmium sulde
quantum dots under neutral-pH condition for biological applications,
J. Colloid Interface Sci., 2012, 390, (1), pp. 310
Liu, Y.F., Yu, J.S.: Selective synthesis of CdTe and high luminescence
CdTe/CdS quantum dots: the effect of ligands, J. Colloid Interface
Sci., 2009, 333, (2), pp. 690698
Biju, V., Mundayoor, S., Omkumar, R.V., Anas, A., Ishikawa, M.:
Bioconjugated quantum dots for cancer research: present status,
prospects and remaining issues, Biotechnol. Adv., 2010, 28, (2),
pp. 199213
Yan, M., Zhang, Y., Xu, K., Fu, T., Qin, H., Zheng, X.: An in vitro
study of vascular endothelial toxicity of CdTe quantum dots,
Toxicology, 2011, 282, (3), pp. 94103
Chen, N., He, Y., Su, Y., et al.: The cytotoxicity of cadmium-based
quantum dots, Biomaterials, 2011, 33, (5), pp. 12381244
Ye, L., Yong, K.T., Liu, L., et al.: A pilot study in non-human
primates shows no adverse response to intravenous injection of
quantum dots, Nat. Nanotechnol., 2012, 7, (7), pp. 453458
Su, Y., Peng, F., Jiang, Z., et al.: In vivo distribution,
pharmacokinetics,
and
toxicity
of
aqueous
synthesized
cadmium-containing quantum dots, Biomaterials, 2011, 32, (25),
pp. 58555862
Hardman, R.: A toxicologic review of quantum dots: toxicity depends
on physicochemical and environmental factors, Environ. Health
Perspect., 2006, 114, (2), p. 165
Pelley, J.L., Daar, A.S., Saner, M.A.: State of academic knowledge on
toxicity and biological fate of quantum dots, Toxicol. Sci., 2009, 112,
(2), pp. 276296
Hoshino, A., et al.: Applications of T-lymphoma labeled with
uorescent quantum dots to cell tracing markers in mouse body,
Biochemical and biophysical research communications, 2004, 314,
pp. 4653
Hoshino, A., et al.: Physicochemical properties and cellular toxicity of
nanocrystal quantum dots depend on their surface modication, Nano
Lett., 2004, 4, pp. 21632169
Shiohara, A., et al.: On the cyto-toxicity caused by quantum dots,
Microbiol Immunol, 2004, 48, pp. 669675
Lovric, J., et al.: Differences in subcellular distribution and toxicity of
green and red emitting CdTe quantum dots, J. Molec. Medi., 2005, 83,
pp. 377385
Derfus, A.M., Chan, W.C.W., Bhatia, S.N.: Probing the cytotoxicity
of semiconductor quantum dots, Nano Let., 2004, 4, pp. 1118
Dubertret, B., et al.: In vivo imaging of quantum dots encapsulated in
phospholipid micelles, Science, 2002, 298, pp. l7591762
Jaiswal, J.K., et al.: Long-term multiple color imaging of live cells
using quantum dot bioconjugates, Nature biotechnology, 2002, 21,
pp. 4751
Larson, D.R., et al.: Water-soluble quantum dots for multiphoton
uorescence imaging in vivo, Science, 2003, 300, pp. l4341436
Voura, E.B., et al.: Tracking metastatic tumor cell extravasation with
quantum dot nanocrystals and uorescence emission-scanning
microscopy, Nature medicine, 2004, 10, pp. 993998
Hanaki, K.-i., et al.: Semiconductor quantum dot/albumin complex is
a long-life and highly photostable endosome marker, Biochemical and
biophysical research communications, 2003, 302, pp. 496501
75

& The Institution of Engineering and Technology 2014

www.ietdl.org
172 Chen, F., Gerion, D.: Fluorescent CdSe/ZnS nanocrystal-peptide
conjugates for long-term, nontoxic imaging and nuclear targeting in
living cells, Nano Lett., 2004, 4, pp. l8271832
173 Chen, N., et al.: The cytotoxicity of cadmium-based quantum dots,
Biomaterials, 2012, 33, pp. l2381244
174 Prasad, B.R., et al.: Long-term exposure of CdTe quantum dots
on PC12 cellular activity and the determination of optimum nontoxic concentrations for biological use, J Nanobiotechnology, 2010,
8, pp. 7

76

& The Institution of Engineering and Technology 2014

175 Su, Y., et al.: The cytotoxicity of cadmium based, aqueous


phase-synthesized, quantum dots and its modulation by surface
coating, Biomaterials, 2009, 30, pp. l925
176 Wang, L., et al.: Toxicity of CdSe nanoparticles in Caco-2 cell
cultures, J. Nanobiotechnology, 2008, 6, pp. 115
177 Tang, M., et al.: Unmodied CdSe quantum dots induce elevation of
cytoplasmic calcium levels and impairment of functional properties of
sodium channels in rat primary cultured hippocampal neurons,
Environmental health perspectives, 2008, 116, pp. 915

IET Nanobiotechnol., 2014, Vol. 8, Iss. 2, pp. 5976


doi: 10.1049/iet-nbt.2012.0028

You might also like